{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:56:52Z","timestamp":1794380212625,"version":"4.9.0"},"reference-count":10,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Neurodegenerative disorders, which are defined by the breakdown of neurons over time, are affecting an increasing number of people. Stroke, Alzheimer's, Parkinson's, Multiple Sclerosis, Migraine, and Amyotrophic Lateral Sclerosis are just a few examples of brain disorders that have no cure. Besides, there is a huge demand for drugs that can cure the diseases mentioned above because the majority of the medications we use to treat them only alleviate diseases. Different neurological disorders have responded satisfactorily to the pharmacological effects of medicinal plants. Despite the numerous multiple types of plants in the world, only a small number of them have been investigated for neurological disorders. As a result, there are many opportunities in this area for further research on plants and their bioactive chemicals. The search for natural therapeutic alternatives that promote faster healing and adverse effects avoidance has gained popularity in recent years. The aim of this mini-review is to explore some natural products that have strong therapeutic effects on neurodegenerative disorders such as Stroke, Alzheimer\u2019s Disease, Parkinson\u2019s Disease, Multiple Sclerosis, Migraine, Amyotrophic Lateral Sclerosis, and others. We have also shown the safety of natural products to improve their appropriate usage in neurological disorders from recent literature.<\/jats:p>","DOI":"10.3389\/fphar.2022.950457","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T09:41:22Z","timestamp":1660902082000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Potential therapeutics against neurological disorders: Natural products-based drugs"],"prefix":"10.3389","volume":"13","author":[{"given":"Abdur","family":"Rauf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Mominur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/MA15030804","article-title":"Applications of Phyto-Nanotechnology for the Treatment of Neurodegenerative Disorders","volume":"15","author":"Bhattacharya","year":"2022","journal-title":"Materials"},{"key":"B2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/2045125317737264","article-title":"The Role of Selective Serotonin Reuptake Inhibitors in Preventing Relapse of Major Depressive Disorder","volume":"8","author":"Clevenger","year":"2017","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, Regional, and National Burden of 12 Mental Disorders in 204 Countries and Territories, 1990\u20132019: a Systematic Analysis for the Global Burden of Disease Study 2019","volume":"9","author":"Ferrari","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/AHMT.S237807","article-title":"Young People\u2019s Response to Parental Neurological Disorder: A Structured Review","volume":"11","author":"Hartman","year":"2020","journal-title":"Adolesc. Health Med. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3056847","DOI":"10.1155\/2018\/3056847","article-title":"Natural Products as an Emerging Therapeutic Alternative in the Treatment of Neurological Disorders","volume":"2018","author":"Karim","year":"2018","journal-title":"Evid. Based. Complement. Altern. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"694","DOI":"10.2174\/1871527319666200722153611","article-title":"Prospective Function of Different Antioxidant Containing Natural Products in the Treatment of Neurodegenerative Diseases","volume":"20","author":"Rahman","year":"2020","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B7","doi-asserted-by":"publisher","first-page":"113305","DOI":"10.1016\/J.BIOPHA.2022.113305","article-title":"Recent Advancements of Nanoparticles Application in Cancer and Neurodegenerative Disorders: At a Glance","volume":"153","author":"Rahman","year":"","journal-title":"Biomed. Pharmacother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/BIOLOGY11010147","article-title":"Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives","volume":"11","author":"Rahman","year":"","journal-title":"Biology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/MOLECULES27010233","article-title":"Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects","volume":"27","author":"Rahman","year":"2021","journal-title":"Molecules"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0033820","DOI":"10.1128\/CMR.00338-20","article-title":"A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders","volume":"35","author":"Sorboni","year":"2022","journal-title":"Clin. Microbiol. Rev."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.950457\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T09:41:23Z","timestamp":1660902083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.950457\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":10,"alternative-id":["10.3389\/fphar.2022.950457"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.950457","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"article-number":"950457"}}